Labshake search
Citations for BioLegend :
51 - 100 of 210 citations for Water soluble CdTe CdSe ZnS quantum dots fluorescence λem 740 nm FWHM 60 nm since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2023Quote: ... and soluble anti-CD28 antibody (2.5 µg/mL; BioLegend). Cells were transduced on RetroNectin (100 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... soluble mCD28 (0.5 µg ml-1, clone 37.51, Biolegend), rhIL-2 (50 Uml-1 ...
-
bioRxiv - Immunology 2023Quote: ... soluble αCD28 (Ultra LEAF© purified, clone 37.51, Biolegend) and 20U/ml recombinant murine interleukin 2 (rmIL-2 ...
-
bioRxiv - Immunology 2024Quote: ... and soluble αCD28 (2 μg/ml, clone 37.51, BioLegend) antibodies ...
-
bioRxiv - Immunology 2024Quote: ... soluble α-CD28 (1 µg/ml, Biolegend, cat: 302934), and Th17 skewing cytokines (IL-1β and IL-23 ...
-
bioRxiv - Microbiology 2021Quote: ... malayi were individually incubated at 37 °C in RPMI 1640 with L-glutamine with 125 nM DRAQ5 (Biolegend) for 24-48 hrs ...
-
bioRxiv - Bioengineering 2022Quote: ... Sections were rinsed three times in IF solution and incubated with 300 nM DAPI (BioLegend, San Diego, CA) in deionized water for 15 minutes at room temperature protected from light ...
-
bioRxiv - Immunology 2022Quote: ... were injected into the microfluidic circulation in HBSS with 1% FBS supplemented with 5 nM CXCL10 (Biolegend 573604) or vehicle (PBS) ...
-
bioRxiv - Immunology 2023Quote: ... cells were treated with 81 nM phorbol 12-myristate 13-acetate (PMA) plus 1.34 µM Ionomycin (BioLegend, 423301) for 30 min ...
-
bioRxiv - Immunology 2021Quote: ... soluble CD28 antibody added (clone CD28.2 at 0.5μg/mL) (BioLegend). Other activation types assessed include ...
-
bioRxiv - Immunology 2021Quote: ... 1 ug/ml soluble anti-CD28 antibody (BioLegend, LEAF grade) and 2 ng/ml IL-2 (carrier-free ...
-
bioRxiv - Immunology 2022Quote: ... and 1µg/ml soluble anti-mouse CD28 (Biolegend, Cat.102116) for different time points with or without addition of transporter block (Thermo Scientific ...
-
bioRxiv - Immunology 2022Quote: ... with soluble anti-CD28 (2 μg/mL) (ULTRA-LEAF Biolegend) in the presence or absence of a mouse anti-human PD1 (2 μg/mL ...
-
bioRxiv - Cell Biology 2024Quote: ... and 1 µg / ml soluble anti-CD28 (BioLegend, Cat. # 1002116). Cells were stained for live/dead cells ...
-
bioRxiv - Immunology 2022Quote: ... neutrophils were incubated with autologous activated platelets (1:10 ratio) (65) for 2.5h and human recombinant CCL28 (50 nM) (BioLegend), the CCR3 antagonist SB328437 (10 mM ...
-
bioRxiv - Bioengineering 2020Quote: ... dilutions of the serum were mixed with a constant 3 nM of an HRP conjugated anti-OVA antibody (BioLegend) and incubated for 2 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... Isolated lymphocytes were stimulated with PMA/ionomycin with Brefeldin A (1:500 or equivalent to 1.3 μM Ionomycin and 81 nM PMA, Cell Activation Cocktail, Biolegend) for 5 h at 37°C with 5% CO2 ...
-
bioRxiv - Immunology 2023Quote: ... cells were stimulated with PMA/ionomycin with Brefeldin A (1:500 or equivalent to 1.3 μM ionomycin and 81 nM PMA, Cell Activation Cocktail, Biolegend) for 4 hours ...
-
bioRxiv - Synthetic Biology 2023Quote: ... and incubated overnight at 4 °C on a tube rotator at 18 rpm in 800 μL of PBS/0.2% BSA containing 15 nM human IgG1 (BioLegend) that had been conjugated with Alexa647 using NHS chemistry (Molecular Probes ...
-
bioRxiv - Immunology 2024Quote: ... Optical densities (ODs) were read at 450 nm wavelength using a BioLegend Mini ELISA Plate Reader (BioLegend, Cat# 423555). Samples and standards were analyzed following subtraction of blank wells (1x PBS ...
-
bioRxiv - Microbiology 2020Quote: ... Cells were activated with soluble anti-CD3 (clone UCHT-1) (Biolegend) for 5 days prior to infection or analysis as previously described (27).
-
bioRxiv - Immunology 2022Quote: ... soluble 1 μg/mL anti-mouse CD28 mAb (clone 37.51, BioLegend), and 1 ng/mL mouse IL-2 (BD Biosciences ...
-
bioRxiv - Immunology 2021Quote: ... with 1 ug/ml soluble anti-CD28 antibody (BioLegend, LEAF grade) and 5 ng/ml IL-2 (carrier-free ...
-
bioRxiv - Immunology 2023Quote: ... and soluble anti-CD28 antibody (2 ug/mL, Clone: CD28.2, Biolegend) in the culture medium containing 1×Brefeldin A (Biolegend ...
-
bioRxiv - Immunology 2022Quote: ... and 0.5 µg/ml of soluble anti-CD28 (clone 37.51; Biolegend) mAbs ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... and resuspended in 100 μL Binding Buffer containing 100 nM M1 anti-FLAG antibody labeled with Alexa Fluor 488 and Alexa Fluor 647 anti-human IgG Fc (BioLegend) diluted 1:100 (v/v) ...
-
bioRxiv - Bioengineering 2022Quote: ... Streptavidin-coated nanovials were reconstituted at a five time dilution in Washing Buffer containing 140 nM (20 μg/mL) of each biotinylated antibody or cocktail of antibodies: anti-CD45 (Biolegend) and anti-IFN-γ (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: ... 50,000 CD4+ T cells were added to each well of mBECs in 12-well chamber slides in Hank’s balanced salt solution (HBSS) with 1% FBS supplemented with 5 nM CXCL10 (Biolegend 573604) or vehicle (PBS) ...
-
bioRxiv - Neuroscience 2022Quote: ... neuronal activity was recorded for 15– 30 min daily before and after treatment with recombinant CXCL11 (200 nM, BioLegend #573606) using the Maestro Pro MEA System (Axion BioSystems) ...
-
bioRxiv - Immunology 2023Quote: CAR-NK92 cells and NK92 cells were suspended with fresh culture medium supplied with 2 nM monensin and anti-CD107a-PE antibody (BioLegend) (1:1000 dilution) ...
-
bioRxiv - Evolutionary Biology 2022Quote: ... Cells were centrifuged at 500× g at 4 °C and resuspended in 1/3 strength artificial seawater containing 2 μg/mL calcein AM (Enzo) and 100 nM sytox blue (BioLegend) to monitor viability ...
-
bioRxiv - Immunology 2023Quote: ... followed by staining with a premixed cocktail of the indicated tetramers at a final concentration of 10 nM for 1 hour at RT in the presence of anti-mouse CD16/32 antibody (clone 93, BioLegend). SLO preparations were magnetically enriched for tetramer-specific cells as previously described64 while lung samples were magnetically enriched for CD90.2 expression (Miltenyi) ...
-
bioRxiv - Immunology 2024Quote: ... LAD2 cells were washed and incubated with the reaction products or serum-purified C3 or C3a (100 nM) along with a PE-conjugated anti-LAMP1 antibody (H4A3, Biolegend) for 1 h at 37 °C ...
-
bioRxiv - Cell Biology 2024Quote: ... Excess media was eluted off and replaced with serum-free media containing typically 250 nM MitoSpyTM Red CMXRos (424801, BioLegend)(in some experiments MitoTracker was used instead ...
-
bioRxiv - Cell Biology 2021Quote: ... was used at 2 μg/ml and soluble anti-mouse CD28 (Biolegend) was used at 8 μg/ml ...
-
bioRxiv - Immunology 2022Quote: ... and soluble 1 μg/mL anti-mouse CD28 mAb (clone 37.51, BioLegend) under Th1-polarizing conditions [1 ng/mL mouse IL-2 (BD Bioscience ...
-
bioRxiv - Cell Biology 2021Quote: ... and 2 μg/ml soluble anti-mouse CD28 antibody (102116, BioLegend, USA) in RPMI 1640 medium (21870-076 ...
-
bioRxiv - Bioengineering 2023Quote: 50 μm streptavidin-coated nanovials were reconstituted at a five-time dilution in Washing Buffer containing 270 nM (40 μg/mL) of biotinylated anti-CD63 antibody (Biolegend, 353018). Nanovials were incubated with antibodies for 30 minutes at room temperature on a rotator and washed three times as described above ...
-
bioRxiv - Bioengineering 2023Quote: Streptavidin-coated nanovials were reconstituted at a five time dilution in Washing Buffer containing 140 nM (20 μg/mL) of each biotinylated antibody or cocktail of antibodies: anti-CD45 (Biolegend, 368534) and anti-IFN-γ (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells pre-treated with anti-mouse TfR-1 antibodies (human constant regions) were incubated with 50 nM of a second TfR-1 antibody for detection (R17, rat anti-mouse antibody; BioLegend, 113802). Cells pre-treated with anti-mouse CD98hc antibodies (human constant regions ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells pre-treated with anti-mouse CD98hc antibodies (human constant regions) were incubated with 10 nM of a second CD98hc antibody for detection (RL388, rat anti-mouse antibody; BioLegend, 128202). Non-treated cells were also incubated with the TfR-1 (R17 ...
-
bioRxiv - Bioengineering 2023Quote: ... staining was performed for 30 minutes at 4 C with both 70 nM AlexaFluor647-conjugated HER2 and 1ng/μL anti-DYKDDDDK (anti-FLAG) Tag Antibody-PE (Biolegend, 637310). The 5A12 library was first incubated with either 0.5 nM VEGF (Acro ...
-
bioRxiv - Immunology 2022Quote: ... Cytokine staining of splenocytes after attLm-OVA infection was carried out after re-stimulation of CD8 T cell enriched splenocytes with 50 nM SIINFEKL peptide for 3 hours with Brefeldin A (Biolegend, cat#:420601).
-
bioRxiv - Cell Biology 2023Quote: ... The protein mixture was then added to 800-nm diameter carboxylated polystyrene beads that were coated with a rabbit polyclonal anti-GFP antibody (BioLegend MMS-118P), and incubated for 10 min ...
-
bioRxiv - Microbiology 2021Quote: ... in the presence of 2 μg/mL soluble αCD28 antibody(clone CD28.2, Biolegend). RNAi knockdown of DCAF1 was performed as described before52 using ON-TARGET plusHuman DCAF1 siRNA - SMARTpool (Dharmacon ...
-
bioRxiv - Microbiology 2021Quote: ... in the presence of 2μg/ml soluble anti-CD28 antibody (clone CD28.2, Biolegend). The CEM-A cell line was obtained through NIH AIDS Reagent Program ...
-
bioRxiv - Immunology 2022Quote: ... and a soluble mAb anti-CD3 (clone OKT-3, 140 ng/mL; BioLegend), were added to the medium at day 0 ...
-
bioRxiv - Immunology 2022Quote: ... CD64-PE-Cy7 (1:60, Biolegend), CD11b-BV395 (1:100 ...
-
bioRxiv - Immunology 2022Quote: ... CD64-PE-Cy7 (1:60, Biolegend), CD11b-BV395 (1:200 ...
-
bioRxiv - Biochemistry 2022Quote: Moles of product formed in hydrolysis reactions used for ACE2 activity and specificity profiling were determined by comparing area under the curve for LC chromatograms corresponding to these reactions to areas under the curve observed for control reactions in which > 95% input substrate conversion was achieved by incubation of substrate with 25 nM recombinant human ACE2 commercial standard (BioLegend, San Diego, CA) for between one and four hours pending peptide substrate ...